baber/WOPTO huggingface dataset:
Patent NO-851223-L (NO)
Inventor: HUBER WILLI
IPC: B05B5/053
Filed: 1985-03-26
Abstract: An electrostatic hand spraygun comprising a gun body, a pistol tube composed of insulating material, a handle, an insulation-clad high-voltage generator and a connection for the paint delivery is fashioned such that the gun is particularly small, lightweight and can be effortlessly held in the hand. The gun body preferably composed of aluminium is thereby an essentially cylindrical body which comprises the connection for the paint delivery in the region of its front face at the cylinder jacket. The pistol tube preferably formed of plastic is secured to the front face of the gun body in a fashion secured against twisting and comprises a clover-leaf-shaped cross-section having two through four "leaves". The high-voltage generator is secured in the back region of the gun body (and) to the underside thereof, whereby the cladding of the high-voltage generator is shaped handle-like, the high-voltage generator thus being (a) handle at the same time.
Patent NO-855309-L (NO)
Inventor: SCHUDY KARL-HEINZ
IPC: B42F13/16
Filed: 1985-12-27
Abstract: 1. A ring mechanism, the mechanism cover (1) of which is provided with rivet holes (2, 3) at the ends, with at least one further opening (13) disposed in the region between the rivet holes, and a cup-shaped rivet insertion (12) disposed in the further opening, characterised in that the rivet insertion (12) is captively connected to the mechanism cover (1).
Patent NO-862317-L (NO)
Inventor: TIPTON CRAIG D
IPC: C10M161/00
Filed: 1986-06-10
Abstract: Polymeric compositions which comprise a mixture of (A) at least one oil-soluble polymer which is a homopolymer of a non-aromatic monoolefin or a copolymer of said non-aromatic monoolefin with an aromatic monoolefin, and (B-1) at least one nitrogen-containing ester of a carboxy-containing interpolymer, or (B-2) at least one oil-soluble acrylate polymerization product of at least one acrylate ester, or a mixture of one or more of (B-1) and (B-2). The polymeric compositions of the invention also may contain (C) an effective amount of at least one viscosity-reducing liquid organic diluent such as a naphthenic oil or an alkylated aromatic material. Polymeric compositions of the present invention are useful as additives in transmission fluids (both automatic and manual) and hydraulic fluids, and the transmission fluids and hydraulic fluids containing the polymeric compositions of the present invention exhibit improved shear stability while maintaining desired high and low temperature viscosity characteristics.
Patent NO-880852-L (NO)
Inventor: BOEHNKE KURT
IPC: H05B3/12
Filed: 1988-02-26
Abstract: A ferritic, heat-resistant steel whose behavior at high application temperatures is improved by the combined addition of oxygen affinitive elements. Apart from stabilizing the electric resistance of heating elements by addition of zirconium, titanium and rare earth metal, also the creep elongation of the steel is considerably reduced under load at temperatures above 900 DEG  C., the thermal stress capacity thus being increased. The resulting complex oxide coating increases the protective function with regard to preserving the metallic cross-section in continuous and/or cyclic heat treatments. The steel is composed of: up to 0.10 % C up to 0.80 % Si 0.10 to 0.50 % Mn up to 0.035 % P up to 0.020 % S 12 to 30 % Cr 0.10 to 1.0 % Mo up to 1 % Ni 3.5 to 8 % Al 0.01 to 1 % Zr 0.003 to 0.8 % rare earth metals 0.003 to 0.30 % Ti 0.003 to 0.050 % N remainder Fe and incidental impurities.
Patent NO-902621-L (NO)
Inventor: GALLISTRU ONORIO
IPC: C07C303/32
Filed: 1990-06-13
Abstract: The invention is concerned with an improved process for preparing paraffin-sulfonic acids containing from 10 to 20 carbon atoms, as well as their salts. The process comprises the initial reaction of sulfo-oxidation of the concerned mixture of n-paraffins, the removal of unreacted n-paraffins from the reaction mixture, the removal of the excess of SO2 from said mixture, and the removal from the reaction mixture of the therein formed sulfuric acid, with the simultaneous recovery of the end product. After the removal of SO2, to the reaction mixture hydrogen peroxide is added and the so obtained solution is submitted to one treatment selected from among the following treatments:   (a) addition of an alcohol with a number of carbon atoms comprised within the range of from 4 to 8; (b) heating up to a temperature comprised within the range of from 50 to 150 DEG C and vacuum distillation under a residual pressure comprised within the range of from 5 to 500 mmHg until at least 60% of contained water is distilled off; (c) addition of an either aliphatic or cycloaliphatic paraffin with a number of carbon atoms comprised within the range of from 6 to 8 and distillation of the resulting azeotropic mixture at a temperature comprised within the range of from 20 to 120 DEG C. e
Patent NO-913153-L (NO)
Inventor: SCHNEIDER BERNARD
IPC: B65D51/20
Filed: 1991-08-13
Abstract: The subject of the invention is the assembly of a sealing device (3) and of a container (1) with a neck (2) made of plastic material underneath a tamper-evident lid (8), this sealing device (3) carrying means (25) for forcible axial nesting of the said lid (8), characterised in that the said sealing device (3) is a cap (3) with an opening, equipped with a base or bottom part (4), and in that the said base (4) and the said neck (2) comprise snap-fit means (15), the start of their snap fitting occurring only after the start of the full-section insertion of the said means (25) for nesting of the said lid (8), and, moreover, further down, of the screwing means, the said means (15 and 25) permitting the rupture of the lid (8) and its driving into the said neck (2). 
<??>This invention applies to tamper-evident containers for the hygiene, pharmaceutical, beauty-care, food and cleaning-product industries. 
<IMAGE>
Patent NO-920591-L (NO)
Inventor: MONDADORI CESARE
IPC: A61P25/28
Filed: 1992-02-14
Abstract: 4-(7-Bromo-5-methoxybenzofuran-2-yl)piperidine of the formula I <IMAGE> and its pharmaceutically utilisable salts can be used as pharmaceutical active ingredients for slowing down the degeneration of nerve cells associated with degenerative neurological disorders, and as nootropics for the treatment of disorders which respond to nootropic treatment.
Patent NO-930264-L (NO)
Inventor: HOLLAND KENNETH MICHAEL
IPC: C10B/
Filed: 1993-01-26
Abstract: Apparatus and method for the pyrolysis of waste material which is not itself susceptible to heating by microwave radiation, which method comprises: (a) contacting the waste material, under an atmosphere wherein flame generation is substantially prevented, with a bed of pulverulent carbonaceous material which is susceptible to heating by microwave irradiation; and (b) heating the pulverulent material by means of microwave irradiation such that thermal energy is transferred from the pulverulent material to the waste material so as to cause substantial pyrolysis of the waste material, wherein the waste material is fed to an upper part of the bed of pulverulent material such that the waste material permitted to sink through the bed, and is pyrolysed within the bed. The apparatus comprises: (a) a container (9) which is inert to microwave radiation and capable of retaining the bed of pulverulent material; (b) a reaction chamber (8); (c) a conduit (19) for feeding the waste material to an upper part of the bed of pulverulent material; (d) a microwave generator (10); (e) air locks (12) and (18) for controlling the atmosphere in chamber (8) such that flame generation is prevented in chamber (8); and (f) outlet (20) for removal of gases, evolved on pyrolysis of the waste material, from chamber (8).
Patent NO-930731-L (NO)
Title: Kininogenaseinhibitorer
Inventor: SZELKE MICHAEL
IPC: C07K7/06
Filed: 1993-02-26
Abstract: Kininogenaseinhibitorer, som optimalt ikke overskrider størrelsen av et heksapeptid, represen-tert ved (II), hvor A og B = aminoacyl (omfattende aminoacylanalog) som er de samme eller forskjellige og danner en dipeptidgruppe hvor aminosyren A "har en terminalgruppe og er en hvilken som helst amino- eller iminosyrerest (men fortrinnsvis med D-konfigurasjon, og B er en lipofil aminosyrerest med D- eller L-konfigurasjon, men ikke prolin eller en prolinanalog, eller en konformasjonsanalog av nevnte dipeptidgruppe hvor peptidbindingen er erstattet med -CH-NH- ("redusert"), -CH(OH)-CH- ("hydroksy"), -CO-CH("keto"), -CHCH- ("hydrokarbon") eller en annen konformasjonsetterligning av peptidbindingen og i (III) skal sidekjeden Rvære sidekjeden i en basisk aminosyre eller aminosyreanalog (fortrinnsvis med L-konfigurasjon), og R være H eller lavere alkyl(0-0) eller C eller peptidbindingen omfattende -N(R)- er erstattet, hvilket farer til en konformasjonsetterligning som ovenfor; V = en bindingsøkende eller karbonylaktiverende gruppe, fortrinnsvis valgt fra H (når A eller B må være cykloheksylalanin, fortrinnsvis D dersom den er A eller L dersom den er B) eller alkyl (CCq) eller fluoralkyl (C-C); substituert oksymetylen; tiometylen; sulfoksymetylen; sulfonylmetylen; aminometylen; hydrazino-metylen; -CH-Het (hvor Het = en substituert eller usubstituert heterocyklus); substituert amino (men når den resulterende forbindelse er et sekundært alkylamid, må B ikke være fenylalanin); en aminosyregruppe eller dens ester eller amid; et karboksylisk sekundært amid eller primært amid, når B må være cykloheksylalanin eller adamantylalanin eller en annen svær lipofil, ikke-aromatisk aminosyre (ikke Ala Leu Ile Val Nva Met Nie Phe Tyr Trp Nal (1)); tertiært karboksamid; karboksyalkylgruppe eller dens ester eller amid eller aminoacylderivat.
Patent NO-932442-L (NO)
Inventor: BELLEAU BERNARD
IPC: C07D411/04
Filed: 1993-07-05
Abstract: Use of a compound of formula (I) <CHEM> or a pharmaceutically acceptable derivative thereof in the manufacture of a medicament for the treatment of hepatitis B is disclosed.
Patent NO-933256-L (NO)
Inventor: REDD BRUCE LAWRENCE
IPC: C11D17/00
Filed: 1993-09-13
Abstract: This invention is a mild personal cleansing bar comprising: from about 20 % to about 50 % lathering mild synthetic surfactant and from about 5 % to about 50 % of magnesium soap; wherein the ratio of said lathering mild synthetic surfactant to said soap is from about 10:1 to about 0.4:1; said bar having a pH of from about 6.5 to about 8.5 in a 1 % aqueous solution at 25  DEG C.
Patent NO-934284-L (NO)
Inventor: NYGVIST HAAKAN
IPC: A61P7/02
Filed: 1993-11-26
Abstract: The present invention relates to pharmaceutical compostions containing a defined lipid system of at least two lipid components where at least one of the lipid components is amphiphatic and polar and one is nonpolar wherein the pharmaceutically active compound is a heparin or a fragment thereof. In the compositions a water containing solvent also is included in such an amount that discrete lipid particles are present, and said compositions can be adapted to various administration forms such as rectal, oral, buccal, transdermal etc.
Patent NO-941546-L (NO)
Title: Transdermale butyrofenonblandinger
Inventor: TAKAYASU TOSHIYUKI
IPC: A61K31/445
Filed: 1994-04-27
Abstract: Transdermal butyrofenonblanding som omfatter de folgende bestanddeler: (a) til (f): (a) en vannløselig polymer som består av en monomer inneholdende, helt eller delvis, alifatisk karboksylsyre med en polymeriserbar dobbelbinding eller et salt av kar- boksylsyren, (b) et kryssbindingsmiddel, (c) en kryssbindingspromoter, (d) vann, (e) et butyrofenonlegemiddel, og (f) et løsningsmiddel for butyrofenonlegemidlet (e), som vesentlige bestanddeler. Blandingens pH justeres til å falle i området 5,5 til 8,0. Med blandingen ifølge oppfinnelsen kan konsentrasjonen av den aktive butyrofenonbestanddelen i blod kontrolleres. Blandingen kan utøve sin primære virkning, antibreknings- virkning, uten å forårsake utslett i huden og med mindre uheldige bivirkninger.
Patent NO-941591-L (NO)
Inventor: RITSCHKOFF ANNE-CHRISTINE
IPC: B27K3/38
Filed: 1994-04-29
Abstract: PCT No. PCT/FI92/00293 Sec. 371 Date Apr. 29, 1994 Sec. 102(e) Date Apr. 29, 1994 PCT Filed Oct. 30, 1992 PCT Pub. No. WO93/08971 PCT Pub. Date May 13, 1993The invention concerns a method and a preservative for protecting wood against decay. According to the method wood is treated with a wood preservative capable of preventing the growth and spread of fungi, said preservative containing at least one complexing agent which binds at least a portion of those metals, typically iron and manganese, naturally occurring in wood that are essential to the growth of fungi. The complexing agents employed can be, e.g., ethylenediaminetetra-acetate, ethylene diamine-di-o-hydroxyphenylacetate a polyphospate or a siderophore produced by a microorganisms. The wood preservative used in the method is water-borne and specific to the decay fungi attacking wood.
Patent NO-943094-L (NO)
Inventor: GOSSELIN PETER GEORGE
IPC: B05B11/00
Filed: 1994-08-22
Abstract: A consumer product passage incorporating a mixing chamber for mixing air and liquid. Consumer packages of the present invention are capable of providing excellent spray qualities at typical consumer product flow rates (e.g., less than about 1.0 cubic centimeters per second) while simultaneously maintaining relatively low air to liquid ratios (e.g., less than about 0.06:1 on a mass basis) and relatively low pressures (e.g., less than about 50 psi). The package of the present invention also offers significant environmental and safety advantages. For example, it does not depend upon dissolved propellants; and it permits the use of water in place of volatile solvents as thinning agents since high surface tension fluids are actually sprayed better. Several packages of the present invention are illustrated, including a standard aerosol version, pump and spray versions, and a finger pump version.
Patent NO-944799-L (NO)
Inventor: BERNARDON JEAN-MICHEL
IPC: A61K31/381
Filed: 1994-12-12
Abstract: The invention relates to new biaromatic compounds having a propynyl unit of general formula (I): <IMAGE> and to the use of the latter compounds in pharmaceutical compositions intended for use in human or veterinary medicine (dermatological, rheumatic, respiratory, cardiovascular or ophthalmological conditions, in particular) or alternatively in cosmetic compositions.
Patent NO-951107-L (NO)
Inventor: CLEAR SANDRA HINTZ
IPC: A61F5/44
Filed: 1995-03-23
Abstract: Absorbent articles such as disposable diapers, incontinent briefs, diaper holders, training pants and the like, that have an elastic leg feature that provides dynamic fit around the leg of the wearer. Such absorbent articles comprise a liquid previous topsheet; a liquid impervious backsheet; an absorbent core disposed between the topsheet and the backsheet; and an elastic leg feature comprising an elasticized leg cuff and elasticized thigh panels. The elasticized leg cuff is positioned in at least the center leg zone of the elastic leg feature, and comprises one or more elastic members operatively associated in an elastically contractible condition so that the leg cuff is elastically contractible in generally the longitudinal direction. The elasticized thigh panels comprise a stretch laminate that is mechanically stretched so that the elasticized thigh panel is capable of expanding beyond the original planar state of the absorbent article in at least one direction at an angle from the longitudinal direction.
Patent NO-953060-L (NO)
Title: Forbedret fremgangsmåte for isolering av cefaclor etter enzymatisk acylering
Inventor: GARDNER JOHN PAUL
IPC: C07D501/12
Filed: 1995-08-03
Abstract: Det er tllvelebragt en fremgangsmåte for Isolering av cefaclor fra en acylerlngs-reaksjonsblanding ved tilsetning av antrakinon-1,5-disulfonsyre til bland- ingen. Syren utfelles meget selektivt med cefaclor, slik at isolering og utvinning optimaliseres.
Patent NO-965087-L (NO)
Title: Isolert nukleinsyremolekyl som koder for en tumorrejeksjonsantigenforlöper, og anvendelse derav
Inventor: BOON-FALLEUR THIERRY
IPC: C12Q1/68
Filed: 1996-11-29
Abstract: Det beskrives et nukleinsyremolekyl som koder for en tumorantigenforløper som deretter bearbeides til antigener som presenteres av et HLA-molekyl. HLA-molekylet kan være HLA-A2, HLA-A28, HLA-B13, HLA-B44 eller HLA-Cw6. Anti- genene beskriver også. Disse materialer er anvendelige i diagnostiske og terapeutiske fremgangsmåter. Tumorrejek- sjonsantigenforløperen er ikke tyrosinase, som tidligere har blitt identifisert som en tumorrejeksjonsantigenfor- løper bearbeidet til et antigen som blir presentert av HLA-B44. Figurene viser data for cytolytisk aktivitet av lymfocytter oppnådd i autologe blandete lymfocytt-tumor- celle-kulturer.
Patent NO-965322-L (NO)
Title: Fremgangsmåte ved opprettelse av en funksjonalitetsenhet ved en telekommunikasjonssvitsj
Inventor: SVANFELDT FREDERIK
IPC: H04Q3/00
Filed: 1996-12-12
Abstract: Den foreliggende oppfinnelse vedrører en fremgangs- måte for å opprette felles funksjonalitets-program- vareenheteer (555) som er egnet for å styre en tele- kommunikasjonssvitsj. De felles funksjonalitets- programvareenheter (555) blir opprettet ved at man utfører en domeneanalyse (542) på alle eksisterende telekommunikasjonssvitsjer (502) som resulterer i identifikasjonen av felles konsepter, terminologi, oppførsel og funksjonalitet for alle mulige kombina- sjoner av bærertjenestehåndterere ("bearer service handlers") (BSHer) og typer av maskinvare (HW) for svitsjene. Den felles oppførsel og funksjonalitet blir implementert i en universell felles program- varemal ("Universal Control Software Template") (UCST) (548), et assosiert parameterdefinisjonsdoku- ment ("Parameter Definition Document") (PDD) (544), og en assosiert samling av abstrakte datatype-defi- nisjoner ("Collection of Abstract Data Type Defini- tion") (CADTD) (546). Nevnte UCST blir kompilert og testet med et undersett av nevnte CADTD. Etter at UCST er kompilert og testet, kan en flerhet av fel- les programvarefunksjonsenheter (CSer) for forskjel- lige kombinasjoner av BSH og HW opprettes fra nevnte UCST og nevnte CADTD.
Patent NO-970647-L (NO)
Title: Fluidtapanordning
Inventor: BROWN KENNEDY J
IPC: E21B43/14
Filed: 1997-02-12
Abstract: En fluidtapsanordning (100) har et hus (200), en tetningsenhet (300), et innføringsverktøy (400) og en plugg (500). Huset (200) settes på en produksjonsrørstreng (33) før en brønnboring (I) kompletteres. Pluggen (500) blir festet til innføringsverktøyet (400) og dette blir festet til et vaskerør (90). Fluidtapsanordningen (100) blir aktivisert ved å løfte vaskerøret (90) og innføringsverktøyet (400), som dermed griper pluggen (500) med tetningsenheten (300), tetningsenheten (300) gjør inngrep med huset (200) og skiller pluggen (500) fra innføringsverktøyet (400). Aktivisering av fluidtapsanordningen (100) hindrer fiuidkommunikasjon gjennom denne og reduserer skade på brønnstrukturen bak fiuidtapsanordningen (100) mens kompletteringsoperasjoner blir utført på andre steder i brønnboringen (I). Fluidtapsanordningen (100) aktiviseres ved å presse pluggen (500) gjennom fiuidtapsanordningen med mekanisk kraft eller trykk, eller ved kjemisk errodering av pluggens diameter inntil pluggen passerer gjennom fiuidtapsanordningen (100). Når fiuidtapsanordningen bli deaktivisert, gjenåpnes det isolerte området av brønnboringen (1) for adkomst gjennom produksjonsrørstrengen (33).
Patent NO-971604-L (NO)
Title: Orale sabeluzolsuspensjoner
Inventor: FRANCOIS MARC KAREL JOZEF
IPC: A61K31/445
Filed: 1997-04-08
Abstract: En vandig suspensjon for oral adminstrasjon omfattende sabeluzol og en farmasøytisk akseptabel bærer, hvilken suspensjon har en pH i området 8-10, samt fremstilling derav.
Patent NO-973026-L (NO)
Title: Nye monoklonale antistoffer med virksom inhibitorisk aktivitet mot type II-fosfolipase A2 og proteiner omfattende en del derav
Inventor: KAWAUCHI YASUSHI
IPC: C12P21/08
Filed: 1997-06-27
Abstract: Nytt monoklonalt antistoff som inhiberer aktiviteten av type Il-fos- folipase A2. Antistoffet inhiberer ak- tiviteten til human type Il-fosfolipase A2, apetype Il-fosfolipase A2 og/eller musetype Il-fosfolipase A2, noe som ikke bare gjør denne klinisk anvendbar, men også anvendbar til dette ved prekliniske tester med anvendelse av ape eller mus. Antistoffet, som har en fullstendig ny karakteristikk med hensyn til frigjøring av type Il-fosfolipase A2 bundet til cellemembran, ser ut til sterkt å hemme type Il-fosfolipase A2-aktiviten via en ny mekanisme. Et protein inneholdende det monoklonale antistoff eller en del av dette er anvendbart i form av et legemiddel mot hjerteinfarkt, hjernein- farkt etc, hvorved type Il-fosfolipase A2 deltar.
Patent NO-974662-L (NO)
Inventor: HILMERSSON ANDERS
IPC: G06K/
Filed: 1997-10-09
Abstract: Method and device for checking patterns (1) disposed on a material strip (30) which patterns (1) consist of groups of dark and light areas (2,2*,3,3*) succeeding in the travelling direction (v) of the material strip (30) and the checking respectively, by displacing the position of the dark areas (2,3) and/or the light areas (2*,3*) of one group with respect to a related detector (8,9) in regard to the dark areas (2,3) and/or light areas (2*,3*) of another group with respect to another related detector (8,9) by detecting the existence or non-existence of dark areas and/or light areas and by creating a sequence of output signals dependent on the result of the detection by combining the output signals comprising information concerning said dark or light areas (2,2*,3,3*) of each detector (8,9) with the output signals depending on the detection of one of said dark or light areas (2,2*,3,3*) of the other detector (8,9) in a predetermined way by for example alternately activating each detector (8,9) by the other detector (8,9) and by comparing this sequence of output signals with a predetermined sequence of signals.
Patent NO-980195-L (NO)
Inventor: LUECHINGER JEAN M
IPC: C12R1/045
Filed: 1998-01-15
Abstract: PCT No. PCT/EP96/03129 Sec. 371 Date Dec. 31, 1997 Sec. 102(e) Date Dec. 31, 1997 PCT Filed Jul. 17, 1996 PCT Pub. No. WO97/04005 PCT Pub. Date Feb. 6, 1997The invention concerns new cyclic peptides of general formula (I) in which the letters A to K signify residues of the following amino acids: A is substituted homothreonine of the general formula (II): R1-CH2CH(CH3)-CH(OH)-CH(NHCH3)-COOH in which R1 is n-propyl or propenyl in which the double bond is preferably in the trans configuration; B is  alpha -aminobutyric acid, valine, norvaline or threonine; C is a D-amino acid of the general formula (III): CH3NH-CH(R)-COOH in which R is straight-chain or branched-chain C2-C6 alkyl, alkenyl or alkynyl, whereby these groups may be substituted by hydroxy, amino, C1-C4 alkylamino, C1-C4 dialkylamino, alkoxy or acyloxy, COOR2 or CONHR2 in which R2 is straight-chain or branched-chain C1-C4 alkyl X-R3 in which X is O or S and R3 is straight-chain or branched-chain C1-C4 alkyl, alkenyl or alkynyl and, when X is S, R3 may also by aryl or heteroaryl, halogen, preferably fluorine, cyano, CHR4R5 in which R4 is hydrogen, methyl, ethyl or phenyl and R5 is hydrogen, hydroxy, halogen (preferably fluorine), amino, C1-C4 alkylamino, C1-C4 dialkylamino, acyloxy (preferably acetyloxy), tert-butoxycarbonylamino-ethoxy-ethoxy-acetyloxy or alkoxycarbonyl (preferably butoxycarbonyl); D is N-methyl-gamma-hydroxyleucine or N-methyl-gamma-acetyloxyleucine; E is valine; F, I and J are each N-methylleucine; G is alanine; H is D-alanine or D-serine; and K is N-methylvaline. The invention also concerns the preparation of such peptides and their use in the prevention of infection by the human immunodeficiency virus (HIV).